Nasdaq:US$13.94 (+0.46) | HKEX:HK$22.58 (+1.14) | AIM:£2.16 (+0)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF